Arterial spin labeling identifies tissue salvage and good clinical recovery after acute ischemic stroke

Journal of Neuroimaging

Volumn 23, Issue 3, 2013, Pages 391-396

  Bivard, Andrew ^a   Stanwell, Peter ^a   Levi, Christopher ^a   Parsons, Mark ^b  

^a JOHN HUNTER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

ASL; Clinical outcome; PWI; Stroke

Indexed keywords

ALTEPLASE; IOPROMIDE; FIBRINOLYTIC AGENT; SPIN LABELING;

ADULT; AGED; ARTERIAL SPIN LABELING; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; BRAIN PERFUSION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CONVALESCENCE; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; ELECTRON SPIN RESONANCE; FEMALE; GRAY MATTER; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PERFUSION WEIGHTED IMAGING; RANKIN SCALE; SALVAGE THERAPY; SPIN LABELING; SUSCEPTIBILITY WEIGHTED IMAGING; WHITE MATTER; ACUTE DISEASE; CLINICAL TRIAL; DRUG EFFECTS; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STROKE; TREATMENT OUTCOME; VERY ELDERLY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PROGNOSIS; RECOVERY OF FUNCTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPIN LABELS; STROKE; TREATMENT OUTCOME;

EID: 84879845388     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2012.00728.x     Document Type: Article

References (23)

1. Bivard A, McElduff P, Levi C, et al. Defining the extent of irreversible brain ischemia using perfusion computed tomography. Cerebrovasc Dis 2011;31(3):238-345.
2. Parsons MW, Christensen S, McElduff P, et al. Echoplanar imaging thrombolytic evaluation trial (EPITHET) investigators. Pre-treatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab 2010;30(6):1214-1225.
3. Marckmann P, Skov L, Rossen K. Clinical manifestations of gadodiamide - related nephrogenic systemic fibrosis. Clin Nephrol 2008;69:161-168.
4. Bardin T, Richette P. Nephrogenic systemic fibrosis. Curr Opin Rheumatol 2010;22:54-58.
5. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-774.
6. Chalela JA, Alsop DC, Gonzalez-Atavales JB, et al. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke 2000;31(3):680-687.
7. Viallon M, Altrichter S, Pereira VM, et al. Combined use of pulsed arterial spin-labeling and susceptibility-weighted imaging in stroke at 3T. Eur Neurol 2010;64(5):286-296.
8. Wang DJ, Alger JR, Qiao JX, et al. The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI. Stroke 2012;43(4):1018-1024.
9. Hernandez DA, Bokkers RP, Mirasol RV, et al. Pseudocontinuous arterial spin labeling quantifies relative cerebral blood flow in acute stroke. Stroke 2012;43(3):753-758.
10. Luh WM, Wong EC, Bandettini PA, et al. QUIPSS II with thin-slice TI1 periodic saturation: a method for improving accuracy of quantitative perfusion imaging using pulsed arterial spin labeling. Magn Reson Med 1999;41:1246-1254.
11. Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998;51:418-426.
12. Yang Q. 2009. Method and system for mapping tissue status of acute stroke. PCT International Application PCT/IB2009/007446, filed November 13, 2009.
13. Yang Q. Method and system of obtaining improved data in perfusion measurements. PCT International Application PCT/AU2004/000821. International Publication on 10 November 2005.
14. Bivard A, Spratt N, Levi C, et al. Perfusion computer tomography: imaging and clinical validation in acute ischaemic stroke. Brain 2011;134:3408-3416.
15. Raoult H, Petr J, Bannier E, et al. Arterial spin labeling for motor activation mapping at 3T with a 32-channel coil: reproducibility and spatial accuracy in comparison with BOLD fMRI. Neuroimage 2011;58:157-167.
16. Tanaka Y, Nagaoka T, Nair G, et al. Arterial spin labeling and dynamic susceptibility contrast CBF MRI in postischemic hyperperfusion, hypercapnia, and after mannitol injection. J Cereb Blood Flow Metab 2011;31:1403-1411.
17. Miteff F, Levi CR, Bateman GA, et al. The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke. Brain 2009;132(Pt 8):2231-2238.
18. Wintermark M, Flanders AE, Velthuis B, et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 2006;37:979-985.
19. Marchal G, Young AR, Baron JC. Early post ischemic hyperperfusion: pathophysiologic insights from positron emission tomography. J Cereb Blood Flow Metab 1999;19:467-482.
20. Zaharchuk G, Yamada M, Sasamata M, et al. Is all perfusion-weighted magnetic resonance imaging for stroke equal? The temporal evolution of multiple hemodynamic parameters after focal ischemia in rats correlated with evidence of infarction. J Cereb Blood Flow Metab 2000;20:1341-1351.
21. Zaharchuk G, Yamada M, Sasamata M, et al. Is all perfusion-weighted magnetic resonance imaging for stroke equal? The temporal evolution of multiple hemodynamic parameters after focal ischemia in rats correlated with evidence of infarction. J Cereb Blood Flow Metab 2000;20:1341-1351.
22. Deibler AR, Pollock JM, Kraft RA, et al. Arterial spin-labeling in routine clinical practice, part 2: hypoperfusion patterns. AJNR Am J Neuroradiol 2008;29:1235-1241.
23. Campbell BC, Tu HT, Christensen S, et al. Assessing response to stroke thrombolysis: validation of 24-hour multimodal magnetic resonance imaging. Arch Neurol 2012 Jan;69(1):46-50.